Marshall Wace’s Tiziana Life Sciences TLSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$184K Sell
157,566
-124,451
-44% -$176K ﹤0.01% 2802
2025
Q4
$420K Buy
282,017
+14,005
+5% +$25.2K ﹤0.01% 2314
2025
Q3
$579K Buy
268,012
+243,643
+1,000% +$451K ﹤0.01% 2175
2025
Q2
$38.5K Buy
+24,369
New +$32.6K ﹤0.01% 2613
2021
Q4
Sell
-41,463
Closed -$61K 4274
2021
Q3
$61K Sell
41,463
-72,925
-64% -$135K ﹤0.01% 2926
2021
Q2
$268K Sell
114,388
-72,083
-39% -$178K ﹤0.01% 2363
2021
Q1
$517K Buy
+186,471
New +$619K ﹤0.01% 1925

Other funds holding TLSA

Marshall Wace's TLSA Position: Q1 2026 in Review

Marshall Wace reduced its Tiziana Life Sciences (TLSA) stake by 44% in Q1 2026, selling an estimated $176K and leaving 157,566 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #2802.

Marshall Wace first reported a position in TLSA in Q1 2021 and has held it in 7 quarters since. The position peaked at $579K in Q3 2025. 32 funds tracked by Wall St. Rank hold TLSA as of Q1 2026.

  • Marshall Wace held 157,566 shares of Tiziana Life Sciences worth $184K as of Q1 2026.
  • Marshall Wace sold 124,451 Tiziana Life Sciences shares in Q1 2026, an estimated $176K.
  • Tiziana Life Sciences made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2802 holding.
  • Marshall Wace first reported a position in Tiziana Life Sciences in Q1 2021 and has held it in 7 quarters since.
  • Marshall Wace's Tiziana Life Sciences position peaked at $579K in Q3 2025.
  • 32 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.